- Full-year organic revenue growth guidance cut to ~2.5% from 3-5%.
- Q3 organic revenue: £2.87B, +2.6% YoY.
Haleon lowered its full-year organic revenue growth forecast to around 2.5% from 3-5% after weak cough and cold medication sales, especially in North America. Q3 organic revenue rose 2.6% to £2.87B. Shares fell 13.5%.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.